Ontario’s New Biosimilar Drug Initiative and It’s Affect On Employee Benefit Plans

Ontario’s New Biosimilar Drug Initiative and It’s Affect On Employee Benefit Plans As of March 2023, Ontario Drug Benefits (ODB) patients that are on biological drugs are required to begin the transition to the biosimilar equivalent. A biosimilar is a biologic drug that is highly similar to a biologic drug that was already authorized for […]